Do incentives from Big Pharma influence the way doctors treat cancer patients? A study published earlier this year in JAMA Oncology says YES.
The first study to evaluate reimbursement policies and clinical care in oncology, the review found that oncologists often change their treatment recommendations and prescriptions based on incentives from the pharmaceutical industry.
(Natural News) President Trump is draining the “medical swamp.” The U.S. health care system is plagued by rampant fraud, abuse and profiteering carried out by dishonest doctors and pharmacists. In working to combat the rampant fraud, the DOJ has announced an unprecedented crackdown on medical fraud, charging over 600 people with criminal activities that involved…Read more
“The cannabinoids in cannabis — cannabidiol (CBD) and tetrahydrocannabinol (THC) — interact with your body by way of naturally-occurring cannabinoid receptors embedded in cell membranes throughout your body. In fact, scientists now believe the endocannabinoid system may represent the most widespread receptor system in your body.1
There are cannabinoid receptors in your brain, lungs, liver, kidneys, immune system and more, and both the therapeutic and psychoactive properties of marijuana occur when a cannabinoid activates a cannabinoid receptor. Your body actually makes its own cannabinoids, similar to those found in marijuana, albeit in much smaller quantities than you get from the plant.
The fact that your body is replete with cannabinoid receptors, key to so many biological functions, is why there’s such enormous medical potential for cannabis. More often than not, medicinal marijuana is made from plants bred to have high CBD and low THC content. While THC has psychoactive activity that can make you feel “stoned,” CBD has no psychoactive properties.